124 related articles for article (PubMed ID: 26652688)
1. Effects of Long-Term Exposure to Free Nε-(Carboxymethyl)lysine on Rats Fed a High-Fat Diet.
Li M; Zeng M; He Z; Zheng Z; Qin F; Tao G; Zhang S; Chen J
J Agric Food Chem; 2015 Dec; 63(51):10995-1001. PubMed ID: 26652688
[TBL] [Abstract][Full Text] [Related]
2. Increased accumulation of protein-bound N(ε)-(carboxymethyl)lysine in tissues of healthy rats after chronic oral N(ε)-(carboxymethyl)lysine.
Li M; Zeng M; He Z; Zheng Z; Qin F; Tao G; Zhang S; Chen J
J Agric Food Chem; 2015 Feb; 63(5):1658-63. PubMed ID: 25611617
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of dietary advanced glycation end products in rats.
Poulsen MW; Andersen JM; Hedegaard RV; Madsen AN; Krath BN; Monošík R; Bak MJ; Nielsen J; Holst B; Skibsted LH; Larsen LH; Dragsted LO
Br J Nutr; 2016 Feb; 115(4):629-36. PubMed ID: 26824730
[TBL] [Abstract][Full Text] [Related]
5. Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat.
Davis KE; Prasad C; Vijayagopal P; Juma S; Adams-Huet B; Imrhan V
Br J Nutr; 2015 Dec; 114(11):1797-806. PubMed ID: 26392152
[TBL] [Abstract][Full Text] [Related]
6. An advanced glycation end product (AGE)-rich diet promotes Nε-carboxymethyl-lysine accumulation in the cardiac tissue and tendons of rats.
Roncero-Ramos I; Niquet-Léridon C; Strauch C; Monnier VM; Tessier FJ; Navarro MP; Delgado-Andrade C
J Agric Food Chem; 2014 Jun; 62(25):6001-6. PubMed ID: 24892987
[TBL] [Abstract][Full Text] [Related]
7. Metabolic transit of N(ε)-carboxymethyl-lysine after consumption of AGEs from bread crust.
Roncero-Ramos I; Delgado-Andrade C; Tessier FJ; Niquet-Léridon C; Strauch C; Monnier VM; Navarro MP
Food Funct; 2013 Jul; 4(7):1032-9. PubMed ID: 23435675
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
[TBL] [Abstract][Full Text] [Related]
9. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
Takeuchi M; Takino J; Furuno S; Shirai H; Kawakami M; Muramatsu M; Kobayashi Y; Yamagishi S
PLoS One; 2015; 10(3):e0118652. PubMed ID: 25730321
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and renal effects of dietary advanced glycation end products in pregnant rats - a pilot study.
Janšáková K; Lengyelová E; Pribulová N; Somoza V; Celec P; Šebeková K; Ostatníková D; Tóthová Ľ
Physiol Res; 2019 Jun; 68(3):467-479. PubMed ID: 30904014
[TBL] [Abstract][Full Text] [Related]
12. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
13. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of organ distribution of dietary protein-bound
Tessier FJ; Niquet-Léridon C; Jacolot P; Jouquand C; Genin M; Schmidt AM; Grossin N; Boulanger E
Mol Nutr Food Res; 2016 Nov; 60(11):2446-2456. PubMed ID: 27393741
[TBL] [Abstract][Full Text] [Related]
16. Carboxymethyl-lysine: thirty years of investigation in the field of AGE formation.
Delgado-Andrade C
Food Funct; 2016 Jan; 7(1):46-57. PubMed ID: 26462729
[TBL] [Abstract][Full Text] [Related]
17. Dietary Intake of Nε-carboxymethyl-lysine, a Major Advanced Glycation End Product, is Not Associated with Increased Risk of Mortality in Japanese Adults in the Takayama Study.
Nagata C; Wada K; Yamakawa M; Nakashima Y; Koda S; Uji T; Oba S
J Nutr; 2020 Oct; 150(10):2799-2805. PubMed ID: 32840609
[TBL] [Abstract][Full Text] [Related]
18. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
Semba RD; Ang A; Talegawkar S; Crasto C; Dalal M; Jardack P; Traber MG; Ferrucci L; Arab L
Eur J Clin Nutr; 2012 Jan; 66(1):3-9. PubMed ID: 21792213
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tissue distribution of free and protein bound Nɛ-carboxymethyllysine after long-term oral administration to mice.
Yuan X; Bai Y; Zhang J; Zhai R; Nie C; Tu A; Li S; Chen Z; Zhang M; Li J
Food Res Int; 2022 Nov; 161():111787. PubMed ID: 36192938
[TBL] [Abstract][Full Text] [Related]
20. Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1
Baskal S; Tsikas SA; Begou O; Bollenbach A; Lenzen S; Jörns A; Tsikas D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
